Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid

Abstract Objectives This study aimed to investigate the gene expression of angiogenic marker in surgically treated jawbones and femur on a rat model administrated with zoledronic acid. Results No soft tissue fenestration or bone exposure was found in femur. Delayed soft tissue healing was found in b...

Full description

Bibliographic Details
Main Authors: Jing Wen Li, Jing Yi Wang, Ru Qing Yu, Lei Huo, Li Wu Zheng
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-021-05900-5
_version_ 1818753922124218368
author Jing Wen Li
Jing Yi Wang
Ru Qing Yu
Lei Huo
Li Wu Zheng
author_facet Jing Wen Li
Jing Yi Wang
Ru Qing Yu
Lei Huo
Li Wu Zheng
author_sort Jing Wen Li
collection DOAJ
description Abstract Objectives This study aimed to investigate the gene expression of angiogenic marker in surgically treated jawbones and femur on a rat model administrated with zoledronic acid. Results No soft tissue fenestration or bone exposure was found in femur. Delayed soft tissue healing was found in both ZA group (3 in mandible, 4 in maxilla) and control group (1 in mandible, 2 in maxilla), while exposed bone was found only in the ZA group (1 in maxilla, 2 in mandible). RT-PCR analysis demonstrated no significant difference in gene expression of angiogenetic markers between ZA-treated and control groups in femur and mandible. In the maxilla, the expression of VEGFA and VEGFR-2 in medium-term ZA group was significantly down-regulated compared with that in the control. The ZA treatment does not change significantly the expression of the angiogenic factors in femur and mandible, but significantly downregulates the expression in maxilla in this rat model. The angiogenesis inhibition may contribute to the development of MRONJ but does not play a key role.
first_indexed 2024-12-18T05:15:03Z
format Article
id doaj.art-28afccbea2114c36bc82e6a14e03cf1b
institution Directory Open Access Journal
issn 1756-0500
language English
last_indexed 2024-12-18T05:15:03Z
publishDate 2022-01-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj.art-28afccbea2114c36bc82e6a14e03cf1b2022-12-21T21:19:48ZengBMCBMC Research Notes1756-05002022-01-011511610.1186/s13104-021-05900-5Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acidJing Wen Li0Jing Yi Wang1Ru Qing Yu2Lei Huo3Li Wu Zheng4Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong KongDiscipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong KongDiscipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong KongDepartment of Orthodontics, The First Affiliated Hospital of Zhengzhou UniversityDiscipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong KongAbstract Objectives This study aimed to investigate the gene expression of angiogenic marker in surgically treated jawbones and femur on a rat model administrated with zoledronic acid. Results No soft tissue fenestration or bone exposure was found in femur. Delayed soft tissue healing was found in both ZA group (3 in mandible, 4 in maxilla) and control group (1 in mandible, 2 in maxilla), while exposed bone was found only in the ZA group (1 in maxilla, 2 in mandible). RT-PCR analysis demonstrated no significant difference in gene expression of angiogenetic markers between ZA-treated and control groups in femur and mandible. In the maxilla, the expression of VEGFA and VEGFR-2 in medium-term ZA group was significantly down-regulated compared with that in the control. The ZA treatment does not change significantly the expression of the angiogenic factors in femur and mandible, but significantly downregulates the expression in maxilla in this rat model. The angiogenesis inhibition may contribute to the development of MRONJ but does not play a key role.https://doi.org/10.1186/s13104-021-05900-5Medication-related osteonecrosis of the jawZoledronic acidAnimal modelGene expressionAngiogenic markers
spellingShingle Jing Wen Li
Jing Yi Wang
Ru Qing Yu
Lei Huo
Li Wu Zheng
Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
BMC Research Notes
Medication-related osteonecrosis of the jaw
Zoledronic acid
Animal model
Gene expression
Angiogenic markers
title Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
title_full Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
title_fullStr Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
title_full_unstemmed Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
title_short Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
title_sort expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid
topic Medication-related osteonecrosis of the jaw
Zoledronic acid
Animal model
Gene expression
Angiogenic markers
url https://doi.org/10.1186/s13104-021-05900-5
work_keys_str_mv AT jingwenli expressionofangiogenicmarkersinjawbonesandfemurinaratmodeltreatedwithzoledronicacid
AT jingyiwang expressionofangiogenicmarkersinjawbonesandfemurinaratmodeltreatedwithzoledronicacid
AT ruqingyu expressionofangiogenicmarkersinjawbonesandfemurinaratmodeltreatedwithzoledronicacid
AT leihuo expressionofangiogenicmarkersinjawbonesandfemurinaratmodeltreatedwithzoledronicacid
AT liwuzheng expressionofangiogenicmarkersinjawbonesandfemurinaratmodeltreatedwithzoledronicacid